FDA Panel Says Some Asthma Inhalers are Risky and are not Worth Taking. A FDA Panel said Thursday that the risks of death and serious injury associated with certain of asthma inhalers are greater than the benefits of the drugs. The drugs discussed by panel were: Serevent, Advair, Foradil, and Symbicort. Read more on

http://askcrazy.com/